Todd Bazemore

Insider Reports History

Entity
Individual
Location
C/O Dyax Corp., 55 Network Drive, Burlington, MA
Signature
/s/ Mary Reumuth, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Todd Bazemore:

Stock Role Class Num Shares Value Price $ Report Date Ownership
KALA BIO, Inc. President and Chief Operating Officer Common Stock 83K $394K $4.75 Jun 26, 2024 Direct
KALA BIO, Inc. President and Chief Operating Officer Common Stock 1 $4.75 $4.75 Jun 26, 2024 By son
KALA BIO, Inc. President and Chief Operating Officer Stock Option (right to buy) 29.3K Jan 4, 2024 Direct
Pulmatrix, Inc. Director Stock Option (Right to Buy) 1.7K Jan 26, 2023 Direct

Insider Reports Filed by Todd Bazemore

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KALA KALA BIO, Inc. Jun 26, 2024 1 -$22.1K 4 Jun 27, 2024 President and Chief Operating Officer
KALA KALA BIO, Inc. May 31, 2024 1 -$12.7K 4 Jun 3, 2024 President and Chief Operating Officer
KALA KALA BIO, Inc. Jan 4, 2024 3 -$9.47K 4 Jan 5, 2024 President and Chief Operating Officer
KALA Kala Pharmaceuticals, Inc. Jun 22, 2023 2 $0 4 Jun 23, 2023 President and Chief Operating Officer
KALA Kala Pharmaceuticals, Inc. May 31, 2023 9 $0 4 Jun 2, 2023 President and Chief Operating Officer
KALA Kala Pharmaceuticals, Inc. Mar 14, 2023 1 $0 4 Mar 15, 2023 President and Chief Operating Officer
PULM Pulmatrix, Inc. Jan 26, 2023 1 $0 4 Jan 30, 2023 Director
KALA Kala Pharmaceuticals, Inc. Jan 4, 2023 2 -$1.77K 4 Jan 6, 2023 President and Chief Operating Officer
KALA Kala Pharmaceuticals, Inc. Oct 26, 2022 1 -$1.39K 4 Oct 28, 2022 President and Chief Operating Officer
KALA Kala Pharmaceuticals, Inc. Jun 27, 2022 1 -$1.14K 4 Jun 29, 2022 President and Chief Operating Officer
PULM Pulmatrix, Inc. Jan 27, 2022 1 $0 4 Jan 28, 2022 Director
KALA Kala Pharmaceuticals, Inc. Jan 3, 2022 2 -$4.49K 4 Jan 5, 2022 President and Chief Operating Officer
KALA Kala Pharmaceuticals, Inc. Oct 26, 2021 1 -$22.6K 4 Oct 28, 2021 CHIEF OPERATING OFFICER
KALA Kala Pharmaceuticals, Inc. Jun 28, 2021 1 -$16.8K 4 Jun 29, 2021 CHIEF OPERATING OFFICER